Next-generation sequencing applications are becoming the building blocks for clinical diagnostics. These experiments require numerous wet- and drylab steps, each one increasing the probability of a sample swap and/or contamination. Therefore, an identity confirmation at the end of the process is required to ensure the right data is used for each patient. We tested three commercially available, SNP bases sample tracking kits in a diagnostic workflow to evaluate their performance. The coverage uniformity, on-target specificity, sample identification and genotyping performance were determined to measure the reliability and estimate the cost-effectiveness of each kit. Our findings showed that the kit from Swift did not perform up to standards as only 20 out of the 46 samples were correctly genotyped. The kit provided by Nimagen identified all but one sample and the kit from pxlence unambiguously identified all samples, making it the most reliable and robust kit of this evaluation. The kit from Nimagen showed poor on-target rates, resulting in deeper sequencing needs and higher sequencing costs compared to the other two kits.